title: Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression.
authors.affiliation: Department of Surgery, University of Minnesota, Minneapolis.
authors.forename: S A
authors.initials: SA
authors.lastname: Gruber
authors.forename: K L
authors.initials: KL
authors.lastname: Skjei
authors.forename: R B
authors.initials: RB
authors.lastname: Sothern
authors.forename: L
authors.initials: L
authors.lastname: Robison
authors.forename: P
authors.initials: P
authors.lastname: Tzardis
authors.forename: A
authors.initials: A
authors.lastname: Moss
authors.forename: K
authors.initials: K
authors.lastname: Gillingham
authors.forename: D M
authors.initials: DM
authors.lastname: Canafax
authors.forename: A J
authors.initials: AJ
authors.lastname: Matas
authors.forename: D L
authors.initials: DL
authors.lastname: Dunn
mesh_terms: D000367:Age Factors; D003524:Cyclosporins / Q000009:adverse effects*; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects* / Q000379:methods; D016030:Kidney Transplantation / Q000009:adverse effects*; D008223:Lymphoma / Q000453:epidemiology / Q000209:etiology; D008297:Male; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology*; D012737:Sex Factors; D012878:Skin Neoplasms / Q000453:epidemiology / Q000209:etiology
chemical_list: D003524:Cyclosporins